SV2A

Synaptic vesicle glycoprotein 2A is a ubiquitous synaptic vesicle protein that in humans is encoded by the SV2A gene. The protein is targeted by the anti-epileptic drugs (anticonvulsants) levetiracetam and brivaracetam.

SV2A
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesSV2A, SV2, synaptic vesicle glycoprotein 2A
External IDsOMIM: 185860 MGI: 1927139 HomoloGene: 32237 GeneCards: SV2A
Orthologs
SpeciesHumanMouse
Entrez

9900

64051

Ensembl

ENSG00000159164

ENSMUSG00000038486

UniProt

Q7L0J3

Q9JIS5

RefSeq (mRNA)

NM_014849
NM_001278719
NM_001328674
NM_001328675

NM_022030

RefSeq (protein)

NP_001265648
NP_001315603
NP_001315604
NP_055664

NP_071313

Location (UCSC)Chr 1: 149.9 – 149.92 MbChr 3: 96.09 – 96.1 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.